<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01445171</url>
  </required_header>
  <id_info>
    <org_study_id>2009-01</org_study_id>
    <nct_id>NCT01445171</nct_id>
  </id_info>
  <brief_title>Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve</brief_title>
  <acronym>TRITON</acronym>
  <official_title>Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical investigation is to confirm that the safety and performance of
      the EDWARDS INTUITY Valve System.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a two-phase, non-randomized, prospective, single arm, multi-center clinical
      investigation. Each subject in Phase 1 and Phase 2 is consented for a period of 5 years. All
      subjects will be assessed for clinical follow-up at the following intervals: Discharge, 1
      month, 3 months, 1 year and annually thereafter until 5 years of follow-up is achieved per
      subject.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of Heart valve objective performance criteria (OPC)</measure>
    <time_frame>up to 5 years</time_frame>
    <description>Safety Endpoints:
Study valve-related mortality Thromboembolic Events
Study Valve thrombosis
Major Bleeding Events
Study valve paravalvular leakage
Study valve-related endocarditis
Performance Endpoints:
Device Technical Success
Procedure success
New York Heart Association (NYHA)
Hemodynamic performance
All subjects will be assessed for clinical follow-up at the following intervals: Discharge, 1 month, 3 months, 1 year and annually thereafter until 5 years of follow-up is achieved per subject.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite of Hemodynamic Performance</measure>
    <time_frame>At each follow-up interval (up to 5 years)</time_frame>
    <description>All cause mortality, Index valve structural valve deterioration, Hemolysis, Index valve-related reoperation, Index valve Explantation, all adverse events</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">295</enrollment>
  <condition>Aortic Valve Stenosis With Insufficiency</condition>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Study Valve</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects act as own control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aortic Valve Replacement with EDWARDS INTUITY Valve System</intervention_name>
    <description>Aortic Valve bioprosthesis</description>
    <arm_group_label>Study Valve</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Criteria:

        Inclusion Criteria:

          -  18 years or older

          -  Aortic stenosis or stenosis-insufficiency of aortic valve requiring a planned
             replacement as indicated in the preoperative evaluation;

          -  Scheduled to undergo planned aortic valve replacement with or without concomitant
             coronary bypass surgery, MAZE procedure, septal myectomy, pacemaker/ICD implant and or
             atrial appendage occlusion/removal.

          -  Signed and dated the informed consent form prior to investigation procedures;

          -  Geographically stable and agrees to attend Follow up assessments at the hospital of
             surgical services for a maximum of 5 years.

        Exclusion Criteria:

          -  Pure aortic insufficiency

          -  Requires emergency surgery

          -  Aneurysm of the aortic root and/or ascending aorta requiring surgical intervention

          -  Left ventricular ejection fraction of ≤ 25%

          -  Active endocarditis within 3 months prior to the scheduled aortic valve replacement
             surgery

          -  Concomitant valve (mitral, tricuspid, or pulmonic) disease requiring repair with an
             annuloplasty ring or replacement with prosthesis

          -  Prior mitral, tricuspid or pulmonic valve surgery, which included implantation of a
             bioprosthetic valve, mechanical valve, or annuloplasty ring.

          -  Myocardial infarction (MI) within 1 month prior to the scheduled aortic valve
             replacement surgery

          -  Previously implanted with EDWARDS INTUITY Aortic valve; alcohol or drug abuser

          -  Disease limiting life expectancy to less than 12 months

          -  Pregnant or lactating

          -  Currently participating in another drug or device clinical investigation;

          -  Documented blood diatheses

          -  Requires non-cardiac procedures such as carotid procedures or mediastinal tumor
             removal

          -  Had a stroke or transient ischemic attack (TIA) within 6-months prior to scheduled
             aortic valve replacement surgery

          -  Study site pre-operative echocardiograpic assessment shows evidence of an intracardiac
             mass, thrombus, or vegetation

          -  Hemodynamic or respiratory instability requiring inotropic support, mechanical
             circulatory support, or mechanical ventilation within 30 days of procedure

          -  Documented renal insufficiency as determined by Serum creatinine ≥ 200 µmol/L (2.27
             mg/dL) at screening or end-stage renal disease requiring chronic dialysis

          -  Documented hyperparathyroidism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof Axel Haverich</last_name>
    <role>Study Director</role>
    <affiliation>MHH Hannover</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AKH Vienna-Allgemeines Krankenhaus der Stadt Wien; University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerchoff Klinik-Bad Nauheim</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MHH-Medizinische Hoschschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Uniklink Koln-Klinik und Poliklinik fur Herz und Thoraxzchirurgie</name>
      <address>
        <city>Koeln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Leipzig: Herzzentrum Leipzig Gmbh</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universitat Muchen-Grosshadern; Clinic at the University of Munich</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <removed_countries>
    <country>Switzerland</country>
  </removed_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2011</study_first_submitted>
  <study_first_submitted_qc>September 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2011</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

